These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659 [TBL] [Abstract][Full Text] [Related]
12. Lysostaphin: an antistaphylococcal agent. Kumar JK Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China. Yang XY; Li CR; Lou RH; Wang YM; Zhang WX; Chen HZ; Huang QS; Han YX; Jiang JD; You XF J Med Microbiol; 2007 Jan; 56(Pt 1):71-76. PubMed ID: 17172520 [TBL] [Abstract][Full Text] [Related]
14. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization. Shah A; Mond J; Walsh S Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections. McMurray LW; Kernodle DS; Barg NL J Infect Dis; 1990 Sep; 162(3):759-62. PubMed ID: 2388000 [TBL] [Abstract][Full Text] [Related]
16. [Staphylococcal bacteremia. 1. Bacteremia due to methicillin-cephem resistant Staphylococcus aureus]. Shimada K; Oka S; Suzuki H; Inamatsu T; Urayama K Kansenshogaku Zasshi; 1985 May; 59(5):459-63. PubMed ID: 3932532 [No Abstract] [Full Text] [Related]
18. In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus. Alvarez S; Jones M; Berk SL Antimicrob Agents Chemother; 1985 Nov; 28(5):689-90. PubMed ID: 3853963 [TBL] [Abstract][Full Text] [Related]
20. Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of beta-lactams on peptidoglycan structure and susceptibility to lytic enzymes. Qoronfleh MW; Wilkinson BJ Antimicrob Agents Chemother; 1986 Feb; 29(2):250-7. PubMed ID: 2872855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]